Main Category: Endocrinology
Also Included In: Men’s health; Erectile Dysfunction / Premature Ejaculation
Article Date: 20 Jul 2011 – 2:00 PDT
email to a friend
printer friendly
opinions
<!– rate article
Patient / Public:

Testosterone deficiency (TD), often referred to as hypogonadism, is associated with aging and affects approximately 30 percent of men ages 40-79. To highlight some of the challenges and controversies encountered in diagnosis and treatment of men with TD, the authors of a review article in the American Journal of Medicine introduced a clinical vignette to illustrate the implication of TD on men’s overall health and analyzed a number of studies in men receiving Testosterone Replacement Therapy (TRT) to treat TD. The article also provided an algorithm for diagnosis and treatment and addressed the areas of concern and uncertainty involving testosterone replacement therapy (TRT).
The clinical vignette depicted a 52 year old man of Caucasian descent who presented with erectile dysfunction, diminished libido and fatigue. He was 5 feet, 7 inches tall, weighed 217 pounds and had normal blood and laboratory values, except that his blood pressure was high and his serum total testosterone was low and his fasting serum glucose and lipid profiles were high – indicating the presence of metabolic syndrome.
In conclusion, the authors recommend that the man be treated for 2-3 months using TRT, with a follow up to determine the efficacy of the TRT in increasing his testosterone levels to normal levels. Their recommendations are in agreement with many published guidelines and show that the TRT treatment, in conjunction with diet and exercise, will help improve the man’s sexual and physical health.
“This clinical vignette offers important information for general practitioners and provides practical recommendations for diagnosing TD and the novel treatment approaches that could positively impact the overall health of middle-aged men,” said Traish.
By introducing the clinical vignette as a teaching case study the authors re-focused the attention on utilizing not only blood (serum) test for testosterone, but also taking into account the sexual and non-sexual physical symptoms into considerations. The authors also indicated that current data failed to show a significant association between TRT and prostate cancer. TRT has been shown to improve sexual function in men with TD. According to a recent review article in the American Journal of Medicine, TRT might also improve the overall health of men.
Abdulmaged M. Traish, MBA, PhD, professor of Urology and Biochemistry at Boston University School of Medicine (BUSM), is the lead author of the article, which was written as a concise review for primary care physicians about advancements being made in the field of endocrinology and men’s health. This article was written in collaboration with Martin M. Miner, MD, from the Warren Albert School of Medicine at Brown University; Abraham Morgentaler, MD, from Beth Israel Deaconess Medical Center; and Michael Zitzmann, MD, from the University Clinics Muenster, Germany.
Source:
Jenny Eriksen Leary
Boston University Medical Center
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.
Follow us on Twitter Endocrinology headlines
email to a friend
printer friendly version
weekly newsletter
personalize your news
back to top
Testosterone And Hemoglobin
posted by Tom on 20 Jul 2011 at 7:21 am
One might think to be totally safe one might include a vignette which depicts the use of erythropoietin in kidney patients / metabolic syndrome. When THEIR hemoglobin was raised into ‘normal’ they tended to DIE. Testosterone raises red blood cells. Erythropoietin raises red blood cells. IF the body itself is KEEPING the testosterone low in order to regulate red blood cells then artificially raising it might be bad ?
“Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men”
“Hemoglobin and hematocrit increased significantly in a linear, dose-dependent fashion in both young and older men in response to graded doses of testosterone”
| post followup | alert a moderator |
Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.